Visalytics
Visalytics
approved EB-2 (NIW) RFE Issued

Senior Bioanalysis Scientist

Medical Biology · China · 2025-07-08

Processing Time
213 days
Decision Date
2025-07-08
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to use multi-omics tools to investigate disease mechanisms, specifically focusing on inflammatory bowel disease (IBD) and gastrointestinal cancers. This work aims to develop healthcare solutions for chronic conditions and improve public health outcomes through precision medicine.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses public health challenges like IBD and cancer, aligning with U.S. precision medicine goals.

2 Well Positioned to Advance the Endeavor Met

The petitioner holds a Ph.D. and has a citation record including a top-tier first-authored publication.

3 Balance of Interests Met

The petitioner's expertise in multi-omics and disease pathology provides a benefit to the U.S. that outweighs the need for labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in molecular and cellular biology and a record of 150 citations. Evidence included a first-authored paper in the top 20% of its field and an unsolicited invitation to present at a leading regenerative medicine conference, satisfying all three Dhanasar prongs.

Request for Evidence (RFE)

Successfully Addressed

USCIS questioned the national importance and the petitioner's positioning; the response provided citation percentiles and evidence of research implementation by others.

RFE Targets
Substantial Merit and National ImportanceWell Positioned to Advance the Endeavor

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Conference Presentations
Government Alignment
Original Contributions

Similar Cases

Clinical Research Coordinator

Biotechnology · Pakistan

WeGreened EB-2 (NIW) approved
Michigan 47 days 2025-05-12
The petitioner proposes to advance disease prevention and treatment strategies, specifically focusing on inflammatory bowel disease, heart disease, autoimmune disorders, and novel infections. The work involves optimizing and synthesizing predictive, therapeutic, and diagnostic modalities to improve clinical outcomes for pressing health issues.
View Case

Others

Healthcare · India

WeGreened EB-2 (NIW) approved
Minnesota 97 days 2025-01-24
The petitioner proposes to advance research focused on developing cutting-edge molecular diagnostic tools, pioneering innovative treatment strategies, and implementing comprehensive patient care models. Specifically, the work aims to study risk factors and transform the early diagnosis and management of gastrointestinal and liver diseases, including cancer.
View Case

Postdoctoral Researcher

Biotechnology · Pakistan

WeGreened EB-2 (NIW) approved
Massachusetts 68 days 2022-04-30
The petitioner proposes to continue research on the development of state-of-the-art pipelines, algorithms, and systems to predict disease-specific biomarkers and drug effects. His work involves studying the viral microbiome, performing single-cell and epigenetic analyses of gastrointestinal tissue, and investigating noncoding RNAs related to COVID-19, inflammatory bowel disease, and liver fibrosis.
View Case

Researcher

Biotechnology · India

WeGreened EB-2 (NIW) approved
California 108 days 2023-02-06
The petitioner proposes to continue her research on investigating different aspects of intestinal innate immunity to identify novel targets and therapies for inflammatory bowel diseases, including Ulcerative Colitis and Crohn’s disease. Her work specifically focuses on the role of the gut microbiome in obesity and inflammasome activation in pulmonary fibrosis.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-07-08.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 213 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist